Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice (PIONEER REAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04559815
Recruitment Status : Enrolling by invitation
First Posted : September 23, 2020
Last Update Posted : October 30, 2020
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : August 19, 2022
Estimated Study Completion Date : August 19, 2022